EAM Global Investors’s Tandem Diabetes Care TNDM Stock Holding History

EAM Global Investors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-17,125	Closed	-$2.58M	–	289
2021 Q4	$2.58M	Buy	+17,125	New	+$2.31M	0.46%	95
2019 Q4	–	Sell	-22,145	Closed	-$1.31M	–	145
2019 Q3	$1.31M	Sell	22,145 -27,216	-55%	-$1.74M	0.64%	84
2019 Q2	$3.19M	Sell	49,361 -6,120	-11%	-$395K	1.35%	6
2019 Q1	$3.52M	Sell	55,481 -7,741	-12%	-$407K	1.56%	8
2018 Q4	$2.4M	Buy	63,222 +3,816	+6%	+$135K	1.31%	8
2018 Q3	$2.54M	Sell	59,406 -19,132	-24%	-$668K	1.03%	9
2018 Q2	$1.73M	Buy	+78,538	New	+$966K	0.84%	11

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM Global Investors's TNDM Position: Q1 2022 in Review

EAM Global Investors sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 17,125 shares — an estimated $2.58M sold.

EAM Global Investors first reported a position in TNDM in Q2 2018 and held it in 7 quarters. The position peaked at $3.52M in Q1 2019. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

EAM Global Investors reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
EAM Global Investors sold 17,125 Tandem Diabetes Care shares in Q1 2022, an estimated $2.58M.
EAM Global Investors first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 7 quarters.
EAM Global Investors's Tandem Diabetes Care position peaked at $3.52M in Q1 2019.
379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on EAM Global Investors's 13F filing for Q1 2022, filed 13 May 2022.